Takashi Kishimoto
Net worth: 146 455 $ as of 2024-03-30
Profile
Takashi Kei Kishimoto worked as a Senior Director-Inflammation Research at Millennium Pharmaceuticals, Inc. from 1999 to 2006.
He then worked as an Associate Director-Research at Boehringer Ingelheim Corp.
before becoming the Vice President-Discovery Research at Momenta Pharmaceuticals, Inc. from 2006 to 2011.
He then became the Chief Scientific Officer at Selecta Biosciences, Inc. in 2011, where he worked until 2023.
He also worked as a Vice President-Research at Momenta Corp.
Dr. Kishimoto holds a doctorate degree from Harvard University and an undergraduate degree from New College of Florida.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.14% | 2023-05-30 | 225,316 ( 0.14% ) | 146 455 $ | 2024-03-30 |
Former positions of Takashi Kishimoto
| Companies | Position | End |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-11-12 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2011-05-31 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2005-12-31 |
| Momenta Corp. | Chief Tech/Sci/R&D Officer | - |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Chief Tech/Sci/R&D Officer | - |
Training of Takashi Kishimoto
| Harvard University | Doctorate Degree |
| New College of Florida | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
| Momenta Corp. |
- Stock Market
- Insiders
- Takashi Kishimoto
